Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
4.980
-0.140 (-2.73%)
At close: Jun 12, 2026, 4:00 PM EDT
5.01
+0.03 (0.60%)
After-hours: Jun 12, 2026, 7:56 PM EDT
Tilray Brands Revenue
Tilray Brands had revenue of $206.73M in the quarter ending February 28, 2026, with 11.28% growth. This brings the company's revenue in the last twelve months to $858.28M, up 3.82% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$858.28M
Revenue Growth
+3.82%
P/S Ratio
0.69
Revenue / Employee
$301,997
Employees
2,842
Market Cap
594.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 302.60M | 143.77% |
| Dec 31, 2020 | 210.48M | -194.84M | -48.07% |
| May 31, 2020 | 405.33M | 238.35M | 142.74% |
| Dec 31, 2019 | 166.98M | 123.85M | 287.15% |
| Dec 31, 2018 | 43.13M | 22.59M | 110.00% |
| Dec 31, 2017 | 20.54M | 7.89M | 62.43% |
| Dec 31, 2016 | 12.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pacira BioSciences | 734.86M |
| Amphastar Pharmaceuticals | 720.53M |
| Emergent BioSolutions | 676.80M |
| Esperion Therapeutics | 418.24M |
| Ironwood Pharmaceuticals | 361.51M |
| Evolus | 301.79M |
| Canopy Growth | 203.04M |
| Kamada | 181.68M |
TLRY News
- 3 days ago - BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team's Return - GlobeNewsWire
- 4 days ago - Fresh From the U.S., BrewDog Unleashes Iconic American Craft Beers Across the U.K. - GlobeNewsWire
- 4 days ago - Tilray Medical Germany launches ARX - TheFly
- 4 days ago - Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany - GlobeNewsWire
- 10 days ago - Breckenridge Distillery Introduces Breckenridge Rye Whiskey, A Bold New Expression from the World's Highest Distillery - GlobeNewsWire
- 11 days ago - 3 Canadian Marijuana Stocks That Could Help You Make Money - MarijuanaStocks
- 11 days ago - SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer - GlobeNewsWire
- 17 days ago - Top Canadian Marijuana Stocks for Your Watchlist Before June 2026 - MarijuanaStocks